Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features

Summary

The aims of this study are 1) to examine the clinical utility of bupropion hydrochloride extended release (Wellbutrin XL®) in patients with Major Depressive Disorder (MDD) with atypical features; 2) to evaluate the tolerability of bupropion hydrochloride extended release (Wellbutrin XL®) in patients with MDD with atypical features.

Timeline

Start

2010-11

Primary completion

2011-07

Completion

2011-09

Drugs

Indications